ContraFect contrafect.com


Public list: BIO 2016 (619) Pharma Startups (6570)

ContraFect is a biotechnology company committed to developing technologies, treatments, and products that will target and kill the most virulent and resistant microorganisms-including gram-positive bacteria, such as Staphylococcus (MRSA), and viruses, such as Influenza. These therapeutics will remain active regardless of future resistance to synthetic therapies, such as occurs with antibiotics. ContraFect's Mabs target conserved regions on microbes, bypassing changes in targets due to mutation. ...Show all

ContraFect is a biotechnology company committed to developing technologies, treatments, and products that will target and kill the most virulent and resistant microorganisms-including gram-positive bacteria, such as Staphylococcus (MRSA), and viruses...Show all

Company (IPO / Went public)

All investors data 3 Investors

Phone: 212-359-9553

Fax:

28 Wells Avenue

 Yonkers, 10701
 New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ContraFect $38.7M Dec 10, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ContraFect Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors

Board Members

Name Firm
Login to see detailsEquity Source Partners
Login to see detailsAlpha Spring Ltd.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Broth microdilution method for evaluating and determining minimal inhibitory concentration of antibacterial polypeptides May 12, 2017 Dec 01, 2020 Patent
Bacteriophage lysin and antibiotic combinations against gram positive bacteria May 09, 2013 Oct 27, 2020 Patent
Lysin polypeptides active against gram-negative bacteria Sep 16, 2016 Aug 18, 2020 Patent
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof Feb 04, 2015 May 05, 2020 Patent
Bacteriophage lysin and antibiotic combinations against gram positive bacteria Jun 04, 2013 Feb 13, 2018 Patent
See all 17 patents